75
Participants
Start Date
June 30, 2002
Primary Completion Date
August 31, 2014
Study Completion Date
January 31, 2017
Melphalan
"Given on Day -1~Melphalan is administered according to the current SOP."
Ara-C
200 mg/m2 IB BID given on Days -5, -4, -3, -2
VP-16
200 mg/m2 IV BID given on Days -5, -4, -3, -2
BCNU
BCNU 300 mg/m2 IV given on Day -6
Rituxan
375 mg/m2 IB given on Days -6, +14, +21, +28
Stem Cells
Stem cells given on Day 0
Texas Children's Hospital, Houston
The Methodist Hospital, Houston
The Methodist Hospital Research Institute
OTHER
Center for Cell and Gene Therapy, Baylor College of Medicine
OTHER
Baylor College of Medicine
OTHER